---
id: "quote-pharma-publication-standards"
type: "quote"
source_timestamps: ["§ The 4C Framework for Building Generative Readiness"]
tags: ["pharmaceuticals", "metadata"]
related: ["concept-machine-readable-content", "entity-gsk", "entity-christof-wyss"]
speaker: "Christof B. Wyss"
speakers: ["Christof B. Wyss"]
quote: "We know what a high-quality publication looks like for human readers. Now we need to understand what a good publication looks like for the API and the LLM. What are the basics to ensure? What metadata is missing? And what potential Q&A documents should we produce?"
sources: ["geo"]
sourceVaultSlug: "hbr-seg-geo"
originDay: 3
articleStem: "hbr-tier1-01-gen-ai-b2b-buying"
sourceUrl: "https://hbr.org/2026/06/how-gen-ai-is-disrupting-b2b-buying-decisions"
sourceTitle: "How Gen AI is Disrupting B2B Buying Decisions"
---
# Redefining high-quality publications for APIs

> "We know what a high-quality publication looks like for human readers. Now we need to understand what a good publication looks like for the API and the LLM. What are the basics to ensure? What metadata is missing? And what potential Q&A documents should we produce?"
> — [[entity-christof-b-wyss]]

**Why it matters:** Reframes 'quality' from human-reader to machine-reader — the pharma-specific expression of [[concept-machine-readable-content]]. It motivates producing Q&A documents (a form of [[concept-ai-snackable-micro-answers]]) and links to [[entity-gsk]]'s work with [[entity-openevidence]] and the paywall contrarian [[contrarian-paywalls-hurt-influence]].